RE:Market didn't like the report?navajojoe wrote: Revenue was 30% above guidance, and yet ebitda barely met guidance? Like w.t.f.?
And BioClod was barely mentioned, so that may be officially dead.
Nice to see revenue continue to climb, but the ebitda needs to follow.
Pretty obvious that core business isn't sexy at all and we just got another proof today, even after quaterly and annually record revenues SP being smack with decent volume... And some earlier were posting that this stock should be at all time high, come on, ridiculous!!
Maybe some day traders bought in the last days expecting some BC update/news combined with the Financials and are now going out or investors are tired of waiting for HC update/release. What a joke this is, tomorrow April and still nothing, what a shame this story has turned to be....